Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1981 Aug 1;154(2):275–290. doi: 10.1084/jem.154.2.275

Loss of tumor-specific and idiotype-specific immunity with age

PMCID: PMC2186407  PMID: 6973599

Abstract

The ultraviolet light-induced fibrosarcoma 1591 undergoes "first-set rejection" when transplanted into normal syngeneic mice. We found, however, that the primary resistance of normal mice decreases with age, beginning at 9--12 mo, equivalent to middle age for mice. Mice lose with age the capacity to mount both idiotypic and anti-idiotypic responses responsible for controlling the growth of tumor. This loss was correlated with quantitative as well as qualitative changes in the response, such as changes in specificity and clonotype. Normal young mice regularly expressed a dominant common anti-1591 "idiotype" as defined by an anti-idiotypic probe. The capability of normal mice to respond with lymphocytes of this dominant common idiotype began to decline at about 8 mo of age. At this time, animals still generated tumor-specific lymphocytes, but these lymphocytes appear to be idiotypically different lymphocyte clones. With further increase in age, animals responded with tumor-reactive lymphocytes that showed a marked cross-reactivity to other tumor target cell lines. Both in vivo and in vitro, the capability of normal mice to mount an immune response that was specific for the 1591 tumor cells decreased between 9 and 14 mo, which was the age individual mice became increasingly susceptible to a challenge with 1591 tumor cells. Thus, our data suggest that clones of tumor-specific T cells provide primary and early protection of young animals against challenge with malignant 1591 cells. However, the dominance of these tumor-specific T cell clones in a primary immune response is lost in middle-age. Because the ability of animals to mount anti-idiotypic immune response also declined in middle-aged animals, it is possible that the observed loss of clonal dominance of tumor- specific clones with increasing age is at least partially related to age-dependent changes in the anti-idiotypic compartment.

Full Text

The Full Text of this article is available as a PDF (945.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguet M., Andersson L. C., Andersson R., Wight E., Binz H., Wigzell H. Induction of specific immune unresponsiveness with purified mixed leukocyte culture-activated T lymphoblasts as autoimmunogen. II. An analysis of the effects measured at the cellular and serological levels. J Exp Med. 1978 Jan 1;147(1):50–61. doi: 10.1084/jem.147.1.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andersson L. C., Aguet M., Wight E., Andersson R., Binz H., Wigzell H. Induction of specific immune unresponsiveness using purified mixed leukocyte culture-activated T lymphoblasts as autoimmunogen. I. Demonstration of general validity as to species and histocompatibility barriers. J Exp Med. 1977 Oct 1;146(4):1124–1137. doi: 10.1084/jem.146.4.1124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bona C., Paul W. E. Cellular basis of regulation of expression of idiotype. I. T-suppressor cells specific for MOPC 460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype. J Exp Med. 1979 Mar 1;149(3):592–600. doi: 10.1084/jem.149.3.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cosenza H., Köhler H. Specific suppression of the antibody response by antibodies to receptors. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2701–2705. doi: 10.1073/pnas.69.9.2701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eichmann K., Falk I., Rajewsky K. Recognition of idiotypes in lymphocyte interactions. II. Antigen-independent cooperation between T and B lymphocytes that possess similar and complementary idiotypes. Eur J Immunol. 1978 Dec;8(12):853–857. doi: 10.1002/eji.1830081206. [DOI] [PubMed] [Google Scholar]
  6. Fisher M. S., Kripke M. L. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Proc Natl Acad Sci U S A. 1977 Apr;74(4):1688–1692. doi: 10.1073/pnas.74.4.1688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Flood P. M., Kripke M. L., Rowley D. A., Schreiber H. Suppression of tumor rejection by autologous anti-idiotypic immunity. Proc Natl Acad Sci U S A. 1980 Apr;77(4):2209–2213. doi: 10.1073/pnas.77.4.2209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gorczynski R. M., Khomasurya B., Kennedy M., MacRae S., Cunningham A. J. Individual-specific (idiotypic) T-B cell interactions regulating the production of anti-2,4,6-trinitrophenyl antibody. II. Development of idiotype-specific helper and suppressor T cells within mice making an immune response. Eur J Immunol. 1980 Oct;10(10):788–791. doi: 10.1002/eji.1830101012. [DOI] [PubMed] [Google Scholar]
  9. Hurt S. N., Berke G., Clark W. A rapid method for generating cytotoxic effector cells in vivo. J Immunol Methods. 1979;28(3-4):321–329. doi: 10.1016/0022-1759(79)90197-2. [DOI] [PubMed] [Google Scholar]
  10. Krammer P. H. Alloantigen receptors on activated T cells in mice. I. Binding of alloantigens and anti-idiotypic antibodies to the same receptors. J Exp Med. 1978 Jan 1;147(1):25–36. doi: 10.1084/jem.147.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kripke M. L. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst. 1974 Nov;53(5):1333–1336. doi: 10.1093/jnci/53.5.1333. [DOI] [PubMed] [Google Scholar]
  12. Kripke M. L., Fisher M. S. Immunologic parameters of ultraviolet carcinogenesis. J Natl Cancer Inst. 1976 Jul;57(1):211–215. doi: 10.1093/jnci/57.1.211. [DOI] [PubMed] [Google Scholar]
  13. Kripke M. L. Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains. Cancer Res. 1977 May;37(5):1395–1400. [PubMed] [Google Scholar]
  14. Kruisbeek A. M., Steinmeier F. A. Alloreactive cytotoxic T lymphocytes from aged mice express increased lysis of autologous and third-party target cells. J Immunol. 1980 Aug;125(2):858–864. [PubMed] [Google Scholar]
  15. PREHN R. T., MAIN J. M. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst. 1957 Jun;18(6):769–778. [PubMed] [Google Scholar]
  16. Roberts L. K., Daynes R. A. Modification of the immunogenic properties of chemically induced tumors arising in hosts treated concomitantly with ultraviolet light. J Immunol. 1980 Jul;125(1):438–447. [PubMed] [Google Scholar]
  17. Sarmiento M., Glasebrook A. L., Fitch F. W. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol. 1980 Dec;125(6):2665–2672. [PubMed] [Google Scholar]
  18. Spellman C. W., Daynes R. A. Immunoregulation by ultraviolet light-III. Enhancement of suppressor cell activity in older animals. Exp Gerontol. 1978;13(3-4):141–146. doi: 10.1016/0531-5565(78)90006-2. [DOI] [PubMed] [Google Scholar]
  19. Spellman C. W., Woodward J. G., Daynes R. A. Modification of immunological potential by ultraviolet radiation. I. Immune status of short-term UV-irradiated mice. Transplantation. 1977 Aug;24(2):112–119. doi: 10.1097/00007890-197708000-00004. [DOI] [PubMed] [Google Scholar]
  20. Steinman R. M., Machtinger B. G., Fried J., Cohn Z. A. Mouse spleen lymphoblasts generated in vitro. Recovery in high yield and purity after floatation in dense bovine plasma albumin solutions. J Exp Med. 1978 Feb 1;147(2):279–296. doi: 10.1084/jem.147.2.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stjernswärd J. Age-dependent tumor-host barrier and effect of carcinogen-induced immunodepression on rejection of isografted methylcholanthrene-induced sarcoma cells. J Natl Cancer Inst. 1966 Oct;37(4):505–512. [PubMed] [Google Scholar]
  22. Stutman O. Cell-mediated immunity and aging. Fed Proc. 1974 Sep;33(9):2028–2032. [PubMed] [Google Scholar]
  23. Szewczuk M. R., Campbell R. J. Loss of immune competence with age may be due to auto-anti-idiotypic antibody regulation. Nature. 1980 Jul 10;286(5769):164–166. doi: 10.1038/286164a0. [DOI] [PubMed] [Google Scholar]
  24. TELLER M. N., CURLETT W., KUBISEK M. L., CURTIS D., STOHR G. AGING AND CANCERIGENESIS. I. IMMUNITY TO TUMOR AND SKIN GRAFTS. J Natl Cancer Inst. 1964 Oct;33:649–656. [PubMed] [Google Scholar]
  25. Woodland R., Cantor H. Idiotype-specific T helper cells are required to induce idiotype-positive B memory cells to secrete antibody. Eur J Immunol. 1978 Aug;8(8):600–606. doi: 10.1002/eji.1830080812. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES